Investigating new treatments for infectious diseases
Official title: Early Phase Clinical Trial Unit
Funded at Icon Government and Public Health Solutions, INC. · NIH-10697191 · Data updated 2026-11-12
This study is looking for people to try out new treatments for infectious diseases to see how well they work and if they're safe, with the hope of finding better options for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icon Government and Public Health Solutions, INC. NIH-funded |
| Lab location | 1 site (Hinckley, United States) |
| Project start | January 14, 2022 |
| Project end | January 13, 2032 |
| Funding year | 2022 |
| Award (this year) | $160,812 |
| NIH project number | 75N93022D00018-0-759302200001-1 |
| Project ID | NIH-10697191 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include individuals diagnosed with infectious diseases who are seeking new treatment options.
✕Less likely to help
Patients with non-infectious diseases or those who do not meet the specific criteria for the trials may not benefit from this research.
What this research studies
This research focuses on early phase clinical trials that explore new agents for treating and preventing infectious diseases. The approach involves implementing interventional strategies to evaluate the effectiveness and safety of these new treatments. Patients may have the opportunity to participate in trials that assess innovative therapies aimed at combating various infectious disorders. The trials are designed to gather essential data that can lead to improved treatment options for patients.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective treatments and preventive measures for infectious diseases.
How similar studies have gone: Other research in early phase clinical trials for infectious diseases has shown promise, indicating that this approach can lead to significant advancements in treatment.
Where this research is happening
-
Icon Government and Public Health Solutions, INC.
Hinckley, United States Active
Researchers
- Principal investigator: Spitz, Robert — Icon Government and Public Health Solutions, INC.
- Study coordinator: Spitz, Robert
Related research
Other NIH-funded projects on the same topics.
-
Investigating new treatments for infectious diseases through early phase clinical trials
This study is looking for people to help test new treatments for infectious diseases, with the hope of finding better ways to prevent and treat these illnesses.
-
Auditing quality assurance for clinical research programs
This study is checking how well clinical trials for infectious diseases are being run to make sure they follow the right rules, which helps ensure that patients get better and safer treatment options.
-
Auditing quality assurance for clinical research programs on infectious diseases.
This study is checking how well clinical trials for infectious diseases are being run to make sure they follow important safety rules, which can help improve the quality of treatments available for patients like you.
-
Evaluating a new treatment for antibiotic-resistant tuberculosis
This study is looking at a new treatment for antibiotic-resistant tuberculosis to see how well it works and how safe it is for patients, so we can find better options for people dealing with this tough infection.
-
Evaluating a new treatment for tuberculosis
This study is looking at a new medication for tuberculosis to see how well it works and if it's safe for people with the condition, and you'll be helping us learn more by trying it out in a clinical trial.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.